Results 1 to 10 of about 7,402 (232)

Delivery and Biosafety of Oncolytic Virotherapy [PDF]

open access: yesFrontiers in Oncology, 2020
In recent years, oncolytic virotherapy has emerged as a promising anticancer therapy. Oncolytic viruses destroy cancer cells, without damaging normal tissues, through virus self-replication and antitumor immunity responses, showing great potential for ...
Lizhi Li   +10 more
doaj   +3 more sources

Oncolytic virotherapy

open access: yesAnnals of Hepatology, 2008
Current oncolytic virotherapy strategies are based in the accumulated understanding of the common molecular mechanisms displayed during cell transformation and viral infection, like cell cycle and apoptosis deregulations.
Daniel Cervantes-García;   +3 more
doaj   +4 more sources

The 16th international oncolytic virotherapy conference: from in vitro to clinical studies, novel approaches in cancer therapy meeting report [PDF]

open access: yesFrontiers in Immunology
The 16th International Oncolytic Virotherapy Conference, which was held in the vibrant city of Rotterdam, Netherlands, on 27-30th November 2024, featured a variety of novel strategies for improving oncolytic virus therapy.
Elena Ekrami   +4 more
doaj   +2 more sources

Syncytia Formation in Oncolytic Virotherapy [PDF]

open access: yesMolecular Therapy: Oncolytics, 2019
Oncolytic virotherapy uses replication-competent virus as a means of treating cancer. Whereas this field has shown great promise as a viable treatment method, the limited spread of these viruses throughout the tumor microenvironment remains a major ...
Chase Burton, Eric Bartee
doaj   +4 more sources

The Multifaceted Role of Macrophages in Oncolytic Virotherapy [PDF]

open access: yesViruses, 2021
One of the cancer hallmarks is immune evasion mediated by the tumour microenvironment (TME). Oncolytic virotherapy is a form of immunotherapy based on the application of oncolytic viruses (OVs) that selectively replicate in and induce the death of tumour
Laura Hofman   +2 more
doaj   +3 more sources

Lung cancer and oncolytic virotherapy——enemy's enemy [PDF]

open access: yesTranslational Oncology, 2023
Lung cancer is one of the malignant tumors that seriously threaten human health worldwide, while the covid-19 virus has become people's nightmare after the coronavirus pandemic. There are too many similarities between cancer cells and viruses, one of the
Zhang Li   +3 more
doaj   +2 more sources

Oncolytic Virotherapy in Glioma Tumors [PDF]

open access: greenInternational Journal of Molecular Sciences, 2020
Glioma tumors are one of the most devastating cancer types. Glioblastoma is the most advanced stage with the worst prognosis. Current therapies are still unable to provide an effective cure. Recent advances in oncolytic immunotherapy have generated great expectations in the cancer therapy field. The use of oncolytic viruses (OVs) in cancer treatment is
Sergio Rius‐Rocabert   +4 more
openalex   +6 more sources

The combination therapy of oncolytic virotherapy. [PDF]

open access: yesFront Pharmacol
Introduction: Compared to other cancer immunotherapies, oncolytic viruses possess several advantages, including high killing efficiency, excellent targeting capabilities, minimal adverse reactions, and multiple pathways for tumor destruction. However, the efficacy of oncolytic viruses as a monotherapy often falls short of expectations.
Wang Y, Zhu M, Chi H, Liu Y, Yu G.
europepmc   +4 more sources

Oncolytic Virotherapy of Canine and Feline Cancer [PDF]

open access: goldViruses, 2014
Cancer is the leading cause of disease-related death in companion animals such as dogs and cats. Despite recent progress in the diagnosis and treatment of advanced canine and feline cancer, overall patient treatment outcome has not been substantially improved.
Ivaylo Gentschev   +5 more
openalex   +6 more sources

Home - About - Disclaimer - Privacy